Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novelion Therapeutics Inc (NASDAQ:NVLN)

9.94
Delayed Data
As of Jun 26
 -0.63 / -5.96%
Today’s Change
6.10
Today|||52-Week Range
13.80
+18.05%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$196.6M

Company Description

Novelion Therapeutics, Inc. develops and markets ocular products. It is engaged in developing new standards of care for individuals living with rare diseases. The company is headquartered in Vancouver, Canada.

Contact Information

Novelion Therapeutics, Inc.
887 Great Northern Way
Vancouver British Columbia V5T 4T5
P:(877) 764-3131
Investor Relations:

Employees

Shareholders

Other institutional69.95%
Mutual fund holders6.37%
Individual stakeholders13.62%

Top Executives

Mary J. SzelaChief Executive Officer & Director
Gregory D. PerryDirector, Chief Financial & Administrative Officer
John J. OrloffEVP, Head of Research & Development
Roger W. LouisChief Compliance Officer
Linda BuonoSenior Vice President-Human Resources